![Nimotuzumab Plus Paclitaxel and Cisplatin as a 1
<sup>st</sup>
-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study]()
Nimotuzumab Plus Paclitaxel and Cisplatin as a 1
<sup>st</sup>
-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II StudyZhang, Xiaodong; Jia, Jun; Lu, Ming; Wang, Xicheng; Gong, Jifang; Li, Jie; Li, Jian; Li, Yan; Zhang, Xiaotian; Lu, Zhihao; Zhou, Jun; Yu, Jing; Sun, Zhiwei; Yang, Ying; Liu, Chuanling; Xiao, Yanjie; Shen, Lin · Journal of Cancer · 2019